Antidepressant Warnings On Pediatric Suicide Need Immediate Strengthening, Cmte. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A joint FDA advisory committee says suicide risk warnings should be communicated to physicians and consumers while the agency re-analyzes pediatric data from antidepressant manufacturers.